ABSTRACT-The distribution of calcitonin gene-related peptide (CGRP) immunoreactivity in the cavernous tissue and the erectile response to intracavernous injection of CGRP was investigated in 7 monkeys. Intracavernous CGRP increased cavernous arterial flow and induced cavernous smooth muscle relaxation and venous outflow occlusion. Intracavernous injection of CGRP antibody did not significantly change the erectile response to cavernous nerve stimulation. Histologic staining for CGRP immunoreactivity showed nerve fiber-like staining within the cavernous arterial wall and the cavernous smooth muscles. These data suggest that CGRP may contribute to penile erection in monkeys.
In 1863 Eckhard' reported that canine penile erection could be induced by stimulation of pelvic parasympathetic nerves. Although acetylcholine is the presumed postganglionic parasympathetic neurotransmitter," Anrep and Cybulsky3 showed about a hundred years ago, that penile erection is atropine-resistant. The latter findings were confirmed in many other studies [4] [5] [6] [7] [8] [9] [10] [11] [12] More recently, we reported that nerve-stimulation-induced erections in monkeys and dogs could be reduced, but not abolished after muscarinic blockade by intracavernous injection of atropine. 13x14 These data showed that acetylcholine was only partly responsible for penile erection, suggesting the presence of additional postganglionic parasympathetic neurotransmitters. A candidate for this noncholinergic parasympathetic neurotransmitter is calcitonin gene-related peptide (CGRP),15 a potent vasodilatorle-l* and smooth muscle relaxant. 1e-22 High concentrations of immunoreactive CGRP are found in penile tissue of the rat. 23 In this in vivo study, we examined functionally and histologically the contribution of CGRP to penile erection in monkeys.
Material and Methods
Seven pigtail monkeys, weighing 4.3 to 8.3 kg, were used. After adequate anesthesia with ketamine (30 mg/kg body weight i.m.), the monkeys were placed in the supine position. Under sterile conditions, a 21-gauge scalp-vein needle was placed bilaterally in the distal cavernous body. One needle was connected to a Statham transducer (model P23 BC) for intracavernous pressure recording (Grass Polygraph; model 7); the other was used for intracavernous injection or perfusion. Penile tumescence was visually monitored by two investigators and recorded; classification of tumescence was done according to the following parameters: E-O = no tumescence; E-l = slight tumescence; E-2 = partial tumescence; E-3 = full tumescence. The flow through the cavernous arteries was measured in 4 monkeys by duplex ultrasound. 24 Pulse and blood pressure were monitored closely with the aid of a Doppler probe (Parks Medical Electronics) on the radial artery and a pediatric blood pressure cuff.
Intracavernous injection of CGRP
In a pilot study, we injected 50, 500, and 2,500 ng CGRP intracavernously in 2 monkeys. A total of 50 ng CGRP induced only a slight, short-lasting tumescence. Because the intracavernous injection of 2,500 ng CGRP lowered the systemic blood pressure by about 35 cm HzO, and the erectile response was similar (only longer lasting) to the response to 500 ng, a dose of 500 ng CGRP was chosen for the following study.
All monkeys received a dose of 500 ng CGRP (Sigma Chemical Co., St. Louis, MO) by intracavernous injection. To verify reproducibility, the injection was repeated on a second day.
Effect of CGRP on cavernous outflow
In all monkeys, the penis was perfused with saline (37°C) at a rate of 26.7 mL/min before and one minute after 500 ng CGRP intracavernously. When the perfusion had continued for sixty seconds or the intracavernous pressure surpassed 300 cm Hz0 (off scale), it was stopped. After a five-minute period, the penis was reperfused. The perfusion series was stopped when two subsequent perfusions evoked responses equal to that prior to the intracavernous injection of CGRP
Erections induced by neurostimulation before and after CGRP-antibody
In 6 monkeys, cuff electrodes were placed around the cavernous nerve as previously described.25 After three erections had been induced by neurostimulation (20 Hz, 6 to 8 V, stimulation time = 1 minute), 500 ng CGRPantibody (Penninsula Lab.) were injected intracavernously and neurostimulation was repeated after one minute and then three times with an eight-minute interval between each stimulation (Fig. 1) .
Histologic staining for CGRP-immunoreactivity
In 2 monkeys, the aorta was clamped and the cavernous bodies were perfused with 500 mL saline, followed by 500 mL phosphate buffer (0.1 M) and fixed with 500 mL phosphate buffered 4% paraformaldehyde.
All perfusion solutions were at 4 "C. The cavernous bodies were removed and sections of approximately 0.5 cm long were placed in the fixation solution for thirty minutes at 4°C. After overnight rinsing in 30 % sucrose, the tissues were embedded (Tissue Tek, Miles Scientific, Naperville, IL) and frozen.
An indirect immunofluorescence technique was used to locate CGRP-immunoreactive fibers. 26 Cryostat sections were cut (16 pm) and placed on lycine-coated slides. The sections were rehydrated with buffer (0.05M PBS + 0.3% Triton-X 100, pH 7.4) for five minutes, then preincubated at room temperature for thirty minutes with 5% goat serum in buffer. After draining but not rinsing, the sections were incubated in a humidified chamber for fortyeight to seventy-two hours at 4 "C with an antibody to CGRP raised in rabbits (Penninsula Lab., San Carlos, CA), dilution 1:lOO. After three ten-minute washes in buffer, the slides were incubated for thirty minutes at 37°C in goat anti-rabbit IgG conjugated to fluoresceinisothiocyanate (FITC) (Cooper Biomedical, Malvern, PA) diluted 1:50. The sections were then washed, mounted with glycerol:PBS (9:l) containing 1.5% 1,4-Diazabicyclo [2.2.2] octane, pH 8.6 (DABCO, Sigma Chemical), and viewed with an Olympus microscope equipped for viewing FITC fluorescence. As method control, tissues were prepared as mentioned, but without adding CGRP-antibody. Statistical analysis was done using the Student t-test.
Results

Zntracavernous injection of CGRP
The first change after the intracavernous injection of 500 ng CGRP was an increase in arterial flow. This was followed by penile tumescence, and then after about one minute, by an increase in intracavernous pressure. Prior to intracavernous injection of CGRP, we could not measure flow velocity of the cavernous artery by duplex ultrasound. After intracavernous injection of CGRP, there was a gradual increase in flow velocity. The flow velocity of the cavernous artery peaked at four minutes (mean) after the injection of CGRP The maximum flow velocity diminished three to four minutes later, We could not detect an arterial flow thirty-two to sixty-nine minutes (mean 49 min) after the intracavernous injection of CGRP (Fig. 2) . Penile tumescence increase was observed about thirty to sixty seconds after the CGRP injections. Maximal tumescence and elongation (E-3) was seen at the time of maximal arterial inflow (mean 4 min after injection) until up to fifteen minutes after the injection. Tumescence then gradually decreased; after a mean of thirty-two minutes, no difference between the tumescence before and after the injection of CGRP could be detected. Intracavernous pressure before CGRP-injection was twenty-four to forty-five cm Hz0 (mean 34). Within ninety to one hundred twenty seconds after the injection, the intracavernous pressure rose to a mean maximum pressure of 62 to 94 cm Hz0 (mean 78). Two to four minutes later, the intracavernous pressure fell within less than sixty seconds to a mean pressure level of 40 to 54 cm Hz0 (mean 47). This pressure gradually declined until baseline pressure was reached after a mean of thirty-six minutes.
Effect of CGRP on cauernom outflow
In the monkeys, saline perfusion at 26.7 mL/ min induced an intracavernous pressure of mean 143 cm Hz0 and slight penile tumescence and elongation (E-l). The response to saline perfusion one minute after the CGRP injection was equal to that before the injection, suggesting that the cavernous smooth muscles are still in the contracted state. After five minutes, saline perfusion showed full venous occlusion (and consequently cavernous smooth muscle relaxation) with full erection in 6 of 7 monkeys; this lasted forty-five to eighty minutes (mean 55). In one monkey, full venous occlusion could not be achieved by a perfusion rate of 26.7 mL/ min (Fig. 3) .
Erections induced by neurostimulation before and after CGRP-antibody
In all monkeys, the erectile response to neurostimulation was not significantly changed after the intracavernous injection of 500 ng CGRP antibody.
Histologic staining for CGRP-immunoreactivity
In the control slides, unspecific staining was found within the endothelium of the arteries. In the slides stained for CGRP immunoreactivity (CGRP-l), nerve fiber-like CGRP-1 was found within the walls of the cavernous arteries and within the cavernous smooth muscles. Dense varicosity-like staining was also found within the cavernous smooth muscles (Fig. 4) .
Comment
Intracavernous injection of CGRP induced an erectile response. This response was due to an increase in arterial flow, relaxation of the cavernous smooth muscles, and occlusion of the venous outflow. The changes in the arterial flow were shown by Duplex sonography of the [20] [21] [22] Intracavernous injection of CGRP antibody did not significantly change the erectile response to neurostimulation. In contrast to VIP antibody that also has a VIP antagonistic effect,28 CGRP antibody seems to have no CGRP antagonistic effect.
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